Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05400213 · ClinicalTrials.gov registry record · NA
Wound Healing Following Tooth Extraction and Ridge Preservation Using DFDBA Alone in Particulate Fiber Form and in Combination With Xenograft
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT05400213 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 102 participants.
The verdict
NCT05400213, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.
Interventions
- DEVICE Vallos (DCP)
- DEVICE Vallomix (DCF)
- DEVICE Vallos-F (DPX)
- DEVICE Vallomix-F (DFX)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2024-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05400213
The ClinicalTrials.gov registry entry for NCT05400213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vallos (DCP) is the first listed.
NCT05400213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05400213 about?
NCT05400213 is a clinical study titled "Wound Healing Following Tooth Extraction and Ridge Preservation Using DFDBA Alone in Particulate Fiber Form and in Combination With Xenograft". The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a co...
What is the current status of trial NCT05400213?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2022-08-02. Estimated completion is 2024-12-18.
What interventions are being tested in trial NCT05400213?
The interventions under investigation include: Vallos (DCP) (DEVICE), Vallomix (DCF) (DEVICE), Vallos-F (DPX) (DEVICE), Vallomix-F (DFX) (DEVICE).
Who is sponsoring clinical trial NCT05400213?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.